Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (359)	11/12/1998 8:47:00 AM
From: Dr. John M. de Castro	Read Replies (1) \| Respond to of 4474

Another ARGENT patent biz.yahoo.com On another subject, the ARIA warrants ARIAW are scheduled to expire in May of next year. The ARIA board should be encouraged to extend the expiration date of these warrants as TXB did for theirs: >> Texas Biotechnology Corporation also announced that the board of >> directors has approved an extension of the exercise period of >> the Company's publicly traded redeemable common stock purchase >> warrants (Amex: TXBWS - news) from December 14, 1998 >> to September 30, 1999. The strike price of $8.44 remains unchanged >> and all other terms of the warrants remain in effect. The >> effective date of the expiration change is December 13, 1998.